The Hemoglobin Level as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer Treated with Gemcitabine and cis-Platinum

Journal Title: Journal of IMAB - Annual Proceeding (Scientific Papers) - Year 2012, Vol 18, Issue 1

Abstract

Objective: Anemia is observed in various malignancies including non- small cell lung cancer /NSCLC/ and is considered to be a poor prognostic factor. The aim of this study is to investigate whether there is a correlation between anemia, other clinic- pathological factors and survival in patients with advanced NSCLC treated with Gemcitabine / cis- Platinum- containing chemotherapy. Methods: Seventy eight consecutive patients with advanced NSCLC treated in Department of Chemotherapy, UMHAT - Dr. G. Stranski, Medical University - Pleven between 2006-2008 were retrospectively analyzed. Of those, 27 patients /34, 6%/ had low hemoglobin /HB/ level (<120g/L for men and <110g/L for women) prior to start chemotherapy. The HB levels were obtained at the time of their first visit to the hospital. All patients received chemotherapy regimen consists of intravenous administration of Gemcitabine 1250 mg/m2 day 1 and 8 and cis- Platinum 80mg/m2 day 1 with repetition over 21 days. Survival analysis was evaluated by Kaplan- Meier test. Results: The median survival time for all patients was 9,5 months. The median survival time for patients with low HB levels was 7,6 months versus 11,3 months in patients without anemia /p<0.05/. There was a significant correlation between anemia and clinical stage or performance status /p<0.05/. Conclusions: These results indicate that patients without anemia have significantly higher survival rate. Pretreatment HB level appears to be a useful prognostic indicator for survival in patients with inoperable NSCLC treated with chemotherapy.

Authors and Affiliations

Deyan Davidov

Keywords

Related Articles

 GENDER DISPARITY IN PREVALENCE OF TUBERCULOSIS IN REGION VARNA IN 2012.

 Aim: To assess the gender differences among suspected pulmonary tuberculosis patients undergoing diagnostic sputum smear microscopy. Materials and methods: The study covered the patients with TBC diagnosed and tr...

CIVIL PROTECTION MODERN ASPECTS IN CASE OF DISASTERS – BULGARIA

This article aims on the modern aspects of Civil Protection in Bulgaria by thorough research of the management and the organization of its activities. We used descriptive analysis and summary of scientific publications a...

OCCLUSION AND ARTICULATION IN BRUXISM AND BRUXOMANIA INVESTIGATED WITH THE SYSTEM T-SCAN III.

 Aim: To be analyzed common features of occlusal relationships in patients with bruxism and bruxomania at maximum intercuspation (MIP) and eccentric jaw movements. Materials and Methods: 30 patients (22 women and...

ALLERGIC CONTACT DERMATITIS FROM FORMALDEHYDE EXPOSURE.

Formaldehyde is a ubiquitous chemical agent, a part of our outdoor and indoor working and residential environment. Healthcare workers in difficult occupations are among the most affected by formaldehyde exposure. Formald...

INTRAOPERATIVE ULTRASOUND EXAMINATION OF HILAR CHOLANGIOCARCINOMA /TUMOR OF KLATSKIN /

Purpose: To compare the opportunities of the intraoperative ultrasound examination of the liver with the preoperative imaging methods – Computer tomography (CT), Ultrasound examination (US) in detecting hepatic lesions...

Download PDF file
  • EP ID EP124904
  • DOI 10.5272/jimab.2012181.209
  • Views 91
  • Downloads 0

How To Cite

Deyan Davidov (2012). The Hemoglobin Level as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer Treated with Gemcitabine and cis-Platinum. Journal of IMAB - Annual Proceeding (Scientific Papers), 18(1), 209-212. https://europub.co.uk/articles/-A-124904